Search This Blog

Monday, April 30, 2018

Allergan CEO: Big deals ‘unlikely’ from review

Says smaller deals more likely on the table. Says a fundamental shift in business strategy “unlikely.”

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.